Article Versions Notes

Soltan MA, Eldeen MA, Sajer BH, Abdelhameed RFA, Al-Salmi FA, Fayad E, Jafri I, Ahmed HEM, Eid RA, Hassan HM, et al. Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy. Biology. 2023; 12(4):613. https://doi.org/10.3390/biology12040613

Soltan, Mohamed A., Muhammad Alaa Eldeen, Bayan H. Sajer, Reda F. A. Abdelhameed, Fawziah A. Al-Salmi, Eman Fayad, Ibrahim Jafri, Hebatallah Emam Mohammed Ahmed, Refaat A. Eid, Hesham M. Hassan, and et al. 2023. "Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy" Biology 12, no. 4: 613. https://doi.org/10.3390/biology12040613

Soltan, M. A., Eldeen, M. A., Sajer, B. H., Abdelhameed, R. F. A., Al-Salmi, F. A., Fayad, E., Jafri, I., Ahmed, H. E. M., Eid, R. A., Hassan, H. M., Al-Shraim, M., Negm, A., Noreldin, A. E., & Darwish, K. M. (2023). Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy. Biology, 12(4), 613. https://doi.org/10.3390/biology12040613